跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Approved
STANDARD
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Eugia Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ede52fa48b539746
Company
Eugia Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
ede52fa48b539746
Product Name
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Artg Id
439214
Artg Name
IRINOTECAN EUGIA irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Sponsor
Eugia Pharma (Australia) Pty Ltd
Company Detail Path
/organization/eugia-pharma-australia-pty-ltd
Artg Date
2025-03-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/d92fdacddaabb1f3e7ca72a42e27b905.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ede52fa48b539746
Type
Standard
Back to TGA Approvals